| Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol (NCT02337270) | McMaster University | 2017-09-05 |
| A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371 (NCT03199339) | Global Alliance for TB Drug Development | 2017-08-29 |
| Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings (NCT03089983) | Yale University | 2017-08-21 |
| Treating Tuberculosis Wasting With a High-protein Supplement (NCT03302949) | University of Aarhus | 2017-08-01 |
| Volatiles in Breath and Headspace Analysis - Diagnostic Markers (NCT03228095) | University of Latvia | 2017-07-24 |
| An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment (NCT03266003) | Centers for Disease Control and Prevention | 2017-07-19 |
| Achieving Tuberculosis (TB) Control In Zambia (NCT03497195) | University of Alabama at Birmingham | 2017-07-01 |
| Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial) (NCT03092817) | Oxford University Clinical Research Unit, Vietnam | 2017-05-25 |
| Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients (NCT03211208) | University of Edinburgh | 2017-05-22 |
| The Impact of Alcohol Consumption on Tuberculosis Treatment Outcomes (NCT02840877) | Boston Medical Center | 2017-05-16 |
| Diagnosis of Tuberculosis in Swiss Children (NCT03044509) | University Children's Hospital Basel | 2017-05-12 |
| Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France (NCT02959684) | University Paris 7 - Denis Diderot | 2017-04-14 |
| Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT) (NCT03302299) | University of California, San Francisco | 2017-04-07 |
| First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects (NCT03075410) | GlaxoSmithKline | 2017-04-02 |
| The Impact of Pharmacists' Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia (NCT04325438) | Bekasi City Public Hospital | 2017-04-01 |
| CD8 Reactivity to Microorganisms in Blood and Breast Milk (NCT03084614) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-28 |
| Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women (NCT02651259) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-13 |
| Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs (NCT03080012) | University Medical Center Groningen | 2017-03-07 |
| Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment (NCT05724212) | Paola Mantegani | 2017-01-27 |
| Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine "GamTBvac" Against the Tuberculosis. (NCT03255278) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2017-01-15 |
| Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community (NCT04947475) | Yale University | 2017-01-01 |
| Phase 2a Study of PBTZ169 (NCT03334734) | Nearmedic Plus LLC | 2016-12-16 |
| Taima TB: 3HP Study (NCT02689089) | Ottawa Hospital Research Institute | 2016-11-28 |
| TB Host Directed Therapy (NCT02968927) | The Aurum Institute NPC | 2016-11-01 |
| The Bioavailability of Rifampicin in (FDCs) Widely Used in South Africa to Treat Drug-susceptible (TB) (NCT02953847) | University of Cape Town | 2016-11-01 |
| Improving the Management of Drug Resistant Tuberculosis in the UK (NCT02875574) | University College, London | 2016-11-01 |
| Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals (NCT02980016) | The Aurum Institute NPC | 2016-11-01 |
| Xpert Active Case-finding Trial 2: Community-based Active Case-finding for Tuberculosis in South Africa (NCT03168945) | University of Cape Town | 2016-11-01 |
| The Correlate of Risk Targeted Intervention Study (NCT02735590) | University of Cape Town | 2016-09-20 |
| Study of TB Lesions Obtained in Therapeutical Surgery (NCT02715271) | Fundació Institut Germans Trias i Pujol | 2016-09-01 |
| Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis (NCT02781909) | Fundació Institut Germans Trias i Pujol | 2016-09-01 |
| Cohort Study on People Who Inject Drugs in Senegal (NCT03459768) | French National Agency for Research on AIDS and Viral Hepatitis | 2016-08-24 |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis (NCT02583048) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-15 |
| Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission (NCT02355223) | Brigham and Women's Hospital | 2016-08-01 |
| Infant TB Infection Prevention Study (NCT02613169) | University of Washington | 2016-08-01 |
| Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa (NCT02808507) | Johns Hopkins Bloomberg School of Public Health | 2016-07-18 |
| Evaluation of Somatostatin Receptor Imaging Using PET/MRI as a Novel Approach to Detecting Pathology in Pulmonary TB (NCT02845570) | National University Hospital, Singapore | 2016-07-01 |
| Effect of Xpert MTB/RIF on Patient Outcomes (NCT02729532) | University of North Carolina, Chapel Hill | 2016-06-22 |
| Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis (NCT02563327) | Centers for Disease Control and Prevention | 2016-05-30 |
| Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy) (NCT02795260) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2016-05-01 |
| Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi (NCT02533089) | Dignitas International | 2016-05-01 |
| Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100) (NCT03559582) | University of Virginia | 2016-04-28 |
| Benin Population Diversity of Tuberculosis and Implications (NCT02744469) | Laboratoire de Référence des Mycobactéries | 2016-04-12 |
| Improving Quality by Maintaining Accurate Problems in the EHR (NCT02596087) | Brigham and Women's Hospital | 2016-04-01 |
| VDOT for Monitoring Adherence to LTBI Treatment (NCT02641106) | University of California, San Diego | 2016-03-08 |
| Aerosol BCG Challenge Trial in Healthy UK Adults (NCT02709278) | University of Oxford | 2016-03-07 |
| DAR-901 TB Booster Vaccine to Prevent TB in Adolescents (NCT02712424) | Dartmouth-Hitchcock Medical Center | 2016-03-01 |
| Training Inmate Peer Educators in Detecting Tuberculosis in a Developing Country Prison: A Cluster Randomized Trial (NCT02744521) | Maastricht University | 2016-03-01 |
| Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers (NCT02700347) | National University Hospital, Singapore | 2016-02-01 |
| TasP in Correctional Facilities (NCT02946762) | University of North Carolina, Chapel Hill | 2016-02-01 |
| Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin (NCT01700790) | University of Miami | 2016-02-01 |
| A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis (NCT02684240) | Weill Medical College of Cornell University | 2016-02-01 |
| Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance (NCT02534727) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-01-27 |
| TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens (NCT02410772) | Centers for Disease Control and Prevention | 2016-01-25 |
| Self-verification and Support Via Mobile Phones Drastically Improves Tuberculosis Treatment Success in LMIC Settings (NCT03135366) | Yale University | 2016-01-04 |
| Phase 1 Study of PBTZ169 (NCT03036163) | Nearmedic Plus LLC | 2016-01-01 |
| Study to Evaluate the Tolerability and Immunogenicity of Nyaditum Resae ® Probiotic Administered to Pediatric Population in Contact With Tuberculosis With or Without Latent Tuberculosis Infection (NCT02581579) | Manresana de Micobacteriologia, SL | 2015-12-09 |
| Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen (NCT02623556) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2015-12-01 |
| An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis (NCT02454205) | University of Cape Town | 2015-11-12 |
| Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis (NCT02778828) | Fondation Hôpital Saint-Joseph | 2015-11-04 |
| PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB (NCT02412436) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-11-03 |
| Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic (NCT02503839) | Anne Margarita Dyrhol Riise | 2015-11-01 |
| Brief Bactericidal Activity of Anti-Tuberculosis Drugs (NCT02236078) | Centers for Disease Control and Prevention | 2015-11-01 |
| Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers (NCT02602509) | National University Hospital, Singapore | 2015-11-01 |
| A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects (NCT02606214) | Global Alliance for TB Drug Development | 2015-11-01 |
| Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection (NCT02687529) | QIAGEN Gaithersburg, Inc | 2015-10-27 |
| Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects (NCT02508376) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-10-22 |
| Virtually Observed Treatment (VOT) for Tuberculosis Patients in Moldova (NCT02331732) | The Behavioural Insights Team | 2015-10-01 |
| Nurse-Led, Symptom-Based Screening of Household Child Contacts of Tuberculosis Index Cases (NCT03074799) | Johns Hopkins University | 2015-10-01 |
| Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB (NCT02619240) | Chinese University of Hong Kong | 2015-10-01 |
| Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis (NCT02273765) | ANRS, Emerging Infectious Diseases | 2015-09-11 |
| Evaluation of South Africa's National Adherence Strategy (NCT02536768) | Boston University | 2015-09-01 |
| Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults (NCT02729571) | Biofabri, S.L | 2015-09-01 |
| Hepatitis B in Cystic Fibrosis and Latent Tuberculosis Respectively (NCT02605538) | Karolinska University Hospital | 2015-09-01 |
| Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases (NCT02807025) | Imperial College Healthcare NHS Trust | 2015-09-01 |
| Doxycycline in Human Pulmonary Tuberculosis (NCT02774993) | National University Hospital, Singapore | 2015-09-01 |
| IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants (NCT02383849) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2015-08-04 |
| Virtual Observed Therapy for Patients With Tuberculosis (NCT02680470) | University of Edinburgh | 2015-08-01 |
| PK Study of Anti-TB Drugs (NCT02457208) | University of Oxford | 2015-07-07 |
| Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples (NCT02497079) | Pusan National University Hospital | 2015-07-01 |
| Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection (NCT02512939) | University College, London | 2015-07-01 |
| Essentiality of INH in TB Therapy (NCT01589497) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-06-30 |
| Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly (NCT02415985) | The HIV Netherlands Australia Thailand Research Collaboration | 2015-06-01 |
| Scaling up TB and HIV Treatment Integration (NCT02654613) | Centre for the AIDS Programme of Research in South Africa | 2015-06-01 |
| Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa (NCT02391415) | Serum Institute of India Pvt. Ltd. | 2015-06-01 |
| A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes (NCT02238405) | Johns Hopkins University | 2015-05-25 |
| Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents (NCT02378207) | Aeras | 2015-05-01 |
| Screening for TB in Pregnancy. on HIV-Infected Pregnant Women (NCT02520973) | Johns Hopkins University | 2015-05-01 |
| Test and Treat TB: A Proof of Concept Trial in South Africa (NCT02298309) | Massachusetts General Hospital | 2015-04-01 |
| Iron Absorption and Utilization During Tuberculosis and After Treatment (NCT02176772) | Swiss Federal Institute of Technology | 2015-04-01 |
| A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania (NCT02382107) | Michael Hoelscher | 2015-03-01 |
| Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention (NCT02430259) | Huashan Hospital | 2015-03-01 |
| Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65 (NCT02389322) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2015-03-01 |
| Evaluation of the QuantiFERON-TB Test. (NCT02253537) | QIAGEN Gaithersburg, Inc | 2015-02-02 |
| Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers (NCT02393586) | National University Hospital, Singapore | 2015-02-01 |
| Heterologous Effects of BCG in Healthy UK Adults (NCT02380508) | University of Oxford | 2015-02-01 |
| Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers (NCT02387242) | National University Hospital, Singapore | 2015-02-01 |
| Yield of Cryoprobe vs Flexible Forceps Pleural Biopsy (NCT02500277) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2015-01-01 |
| Quality of Tuberculosis Care in Mumbai, India (NCT02874755) | McGill University | 2015-01-01 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects (NCT02288481) | Global Alliance for TB Drug Development | 2015-01-01 |